Movatterモバイル変換

[0]ホーム
URL:

CR20130488A - DERIVATIVES OF TIENO [2,3-D] PYRIMIDINE AND ITS USE TO TREAT ARRITMIA - Google Patents

DERIVATIVES OF TIENO [2,3-D] PYRIMIDINE AND ITS USE TO TREAT ARRITMIA

Info

Publication number
CR20130488A
CR20130488ACR20130488ACR20130488ACR20130488ACR 20130488 ACR20130488 ACR 20130488ACR 20130488 ACR20130488 ACR 20130488ACR 20130488 ACR20130488 ACR 20130488ACR 20130488 ACR20130488 ACR 20130488A
Authority
CR
Costa Rica
Prior art keywords
arritmia
tieno
pyrimidine
treat
derivatives
Prior art date
Application number
CR20130488A
Other languages
Spanish (es)
Inventor
Derek Edward John
John Ford
Original Assignee
Xention Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=44071904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20130488(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Xention LtdfiledCriticalXention Ltd
Publication of CR20130488ApublicationCriticalpatent/CR20130488A/en

Links

Classifications

Landscapes

Abstract

Translated fromSpanish

Compuestos de tienopiridimidina que son inhibidores de canal de potasio. Composiciones farmacéuticas que comprenden los compuestos y su uso en el tratamiento de arritmia.Thienopyridimidine compounds that are potassium channel inhibitors. Pharmaceutical compositions comprising the compounds and their use in the treatment of arrhythmia.

CR20130488A2011-04-012013-09-26 DERIVATIVES OF TIENO [2,3-D] PYRIMIDINE AND ITS USE TO TREAT ARRITMIACR20130488A (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GBGB1105659.5AGB201105659D0 (en)2011-04-012011-04-01Compounds

Publications (1)

Publication NumberPublication Date
CR20130488Atrue CR20130488A (en)2013-12-06

Family

ID=44071904

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CR20130488ACR20130488A (en)2011-04-012013-09-26 DERIVATIVES OF TIENO [2,3-D] PYRIMIDINE AND ITS USE TO TREAT ARRITMIA

Country Status (42)

CountryLink
US (1)US9249155B2 (en)
EP (1)EP2694518B1 (en)
JP (1)JP5826374B2 (en)
KR (1)KR20140023332A (en)
CN (1)CN103492392B (en)
AP (1)AP2013007198A0 (en)
AR (1)AR088735A1 (en)
AU (1)AU2012235882B2 (en)
BR (1)BR112013025236A2 (en)
CA (1)CA2831493A1 (en)
CL (1)CL2013002789A1 (en)
CO (1)CO6801756A2 (en)
CR (1)CR20130488A (en)
CU (1)CU24173B1 (en)
CY (1)CY1117025T1 (en)
DK (1)DK2694518T3 (en)
EA (1)EA201301111A1 (en)
EC (1)ECSP13012988A (en)
ES (1)ES2558563T3 (en)
GB (1)GB201105659D0 (en)
GT (1)GT201300225A (en)
HR (1)HRP20151340T1 (en)
HU (1)HUE028438T2 (en)
IL (1)IL228555A0 (en)
MA (1)MA35064B1 (en)
ME (1)ME02314B (en)
MX (1)MX335937B (en)
NI (1)NI201300100A (en)
PE (1)PE20141021A1 (en)
PH (1)PH12013501952A1 (en)
PL (1)PL2694518T3 (en)
PT (1)PT2694518E (en)
RS (1)RS54458B1 (en)
RU (1)RU2013148627A (en)
SG (1)SG193578A1 (en)
SI (1)SI2694518T1 (en)
SM (1)SMT201500322B (en)
TN (1)TN2013000377A1 (en)
TW (1)TWI516265B (en)
UA (1)UA110131C2 (en)
WO (1)WO2012131379A1 (en)
ZA (1)ZA201307085B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2014078957A1 (en)*2012-11-202014-05-30The Royal Institution For The Advancement Of Learning/Mcgill UniversityThienopyrimidine inhibitors of farnesyl and/or geranylgeranyl pyrophosphate synthase
EP3394056B1 (en)2015-12-222021-04-14Shy Therapeutics LLCCompounds for the treatment of cancer and inflammatory disease
CN106727587A (en)*2016-11-282017-05-31李娜A kind of pharmaceutical composition for treating arrhythmia cordis
EP3642209B1 (en)*2017-06-212023-11-29Shy Therapeutics LLCCompounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
WO2020132071A1 (en)2018-12-192020-06-25Shy Therapeutics. LlcCompounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and f1brotic disease

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CH317906A (en)1953-09-161956-12-15Sandoz Ag Process for the preparation of 1-amino-4-oxyanthraquinone sulfonic acids
AU521790B2 (en)1977-05-231982-04-29Ici Australia LimitedProcess for eradication of ticks
ZA782648B (en)1977-05-231979-06-27Ici Australia LtdThe prevention,control or eradication of infestations of ixodid ticks
DD226893A1 (en)1981-12-151985-09-04Ralf Boehm PROCESS FOR PREPARING ARYLAMINOSUBSTITUTED THIENO 2,3-D PYRIMIDINES
IL112566A (en)1994-02-102000-10-31Wyeth John & Brother LtdSubstituted quinolinones and pharmaceutical compositions containing them
IL112568A0 (en)1994-02-101995-05-26Wyeth John & Brother LtdSubstituted quinolines, their preparation and pharmaceutical compositions containing them
IL112567A (en)1994-02-102000-02-29Wyeth John & Brother LtdSubstituted quinolines their preparation and pharmaceutical compositions containing them
IL112569A (en)1994-02-101999-12-22Wyeth John & Brother LtdPharmaceutical compositions comprising cyclohexylamine derivatives certain such novel compounds and their preparation
AU6670196A (en)1995-08-171997-03-12Takeda Chemical Industries Ltd.Thienopyrimidine derivatives, their production and use
ZA976654B (en)1996-07-261998-02-10Nissan Chemical Ind LtdChroman derivatives.
US6083986A (en)1996-07-262000-07-04Icagen, Inc.Potassium channel inhibitors
US5935945A (en)1996-10-311999-08-10Merck & Co., Inc.Methods of treating or preventing cardiac arrhythmia
US5969017A (en)1996-10-311999-10-19Merck & Co., Inc.Methods of treating or preventing cardiac arrhythmia
RU2116309C1 (en)1997-02-131998-07-27Институт медицинской паразитологии и тропической медицины им.Е.И.Марциновского4-[(benzo-2,1,3-thiadiazolyl-4)-amino]-5,6,7,8-tetrahydroben-zothieno-[2,3-d]-pyrimidine showing anthelmintic activity in larval alveolar echinococcosis
US6333337B1 (en)1998-01-272001-12-25Icagen, Inc.Potassium channel inhibitors
AU4411399A (en)1998-06-051999-12-20Eli Lilly And CompanyPotassium channel inhibitors
AU5444499A (en)1998-09-012000-03-21Nissan Chemical Industries Ltd.Benzoxazine derivatives
US6194458B1 (en)1998-10-302001-02-27Merck & Co., Inc.Benzamide potassium channel inhibitors
DE19929076A1 (en)1999-06-252000-12-28Aventis Pharma GmbhNew indanyl-substituted benzenesulfonamide derivatives, as potassium channel blockers useful as safe antiarrhythmic agents, e.g. for treating atrial fibrillation or flutter
AU766935B2 (en)1999-09-172003-10-23Nissan Chemical Industries Ltd.Benzopyran derivative
AU7319800A (en)1999-09-242001-04-24Nissan Chemical Industries Ltd.4-oxybenzopyran derivative
DE19947457A1 (en)1999-10-022001-04-05Aventis Pharma GmbhNew 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter
US6531495B1 (en)1999-10-022003-03-11Aventis Pharma Deutschland Gmbh2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
WO2001025224A1 (en)1999-10-052001-04-12Nissan Chemical Industries, Ltd.4-oxybenzopyran derivative
US6887870B1 (en)1999-10-122005-05-03Bristol-Myers Squibb CompanyHeterocyclic sodium/proton exchange inhibitors and method
MY125533A (en)1999-12-062006-08-30Bristol Myers Squibb CoHeterocyclic dihydropyrimidine compounds
WO2001046155A1 (en)1999-12-212001-06-28Icagen, Inc.Potassium channel inhibitors
EP1322619B1 (en)2000-09-202008-01-23Merck & Co., Inc.Isoquinolinone potassium channel inhibitors
DE10054481A1 (en)2000-11-032002-05-08Aventis Pharma Gmbh Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them
DE10059418A1 (en)2000-11-302002-06-20Aventis Pharma Gmbh Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
DE10060807A1 (en)2000-12-072002-06-20Aventis Pharma Gmbh Ortho, ortho-substituted nitrogen-containing bisaryl compounds, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
DE10061876A1 (en)2000-12-122002-06-20Aventis Pharma Gmbh Arylated furan and thiophene carboxamides, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
EP1357915A2 (en)2001-02-022003-11-05MERCK PATENT GmbHPHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO 4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
DE10104802A1 (en)2001-02-022002-08-08Merck Patent GmbhComposition useful for treating e.g. congestive heart failure, comprising thienopyrimidine phosphodiesterase V inhibitor and endothelin receptor antagonist
TW589305B (en)2001-02-142004-06-01Nissan Chemical Ind Ltd4-aminobenzopyran derivatives
DE10121002A1 (en)2001-04-282002-11-14Aventis Pharma Gmbh Use of anthranilic acid amides as a medicament for the treatment of arrhythmias and pharmaceutical preparations containing them
DE10121003A1 (en)2001-04-282002-12-19Aventis Pharma Gmbh Anthranilic acid amides, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
DE10128331A1 (en)2001-06-122002-12-19Aventis Pharma GmbhNew 2-(heteroarylsulfonyl-amino)-benzamide derivatives, which are potassium ion channel blocking antiarrhythmic agents, useful for e.g. treating atrial fibrillation or flutter
UA77189C2 (en)2001-06-252006-11-15Nissan Chemical Ind LtdBenzopyran derivatives as antiarrhythmic agents
TW200307539A (en)2002-02-012003-12-16Bristol Myers Squibb CoCycloalkyl inhibitors of potassium channel function
WO2004111057A1 (en)*2003-06-112004-12-23Xention Discovery LimitedThienopyrimidine derivatives as potassium channel inhibitors
GB0315950D0 (en)2003-06-112003-08-13Xention Discovery LtdCompounds
CN1845918A (en)*2003-07-022006-10-11沃泰克斯药物股份有限公司 Pyrimidines useful as modulators of voltage-gated ion channels
CN1910190A (en)2004-01-062007-02-07大正制药株式会社Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group
US7776867B2 (en)2004-06-292010-08-17Amgen Inc.Furanopyrimidines
US7576212B2 (en)2004-12-092009-08-18Xention LimitedThieno[2,3-B] pyridines as potassium channel inhibitors
ATE476434T1 (en)2004-12-092010-08-15Xention Ltd THIENOPYRIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS
WO2007084815A2 (en)2006-01-192007-07-26Janssen Pharmaceutica, N.V.Substituted thienopyrimidine kinase inhibitors
MX2008015908A (en)*2006-06-122009-01-28Vertex PharmaThienopyrimidines useful as modulators of ion channels.
DE102009039893B4 (en)2009-09-032012-03-29Bundesanstalt für Materialforschung und -Prüfung (BAM) Use of a fuel in a self-sustaining pulsating oxygen-fuel combustion process

Also Published As

Publication numberPublication date
UA110131C2 (en)2015-11-25
PL2694518T3 (en)2016-03-31
US9249155B2 (en)2016-02-02
AU2012235882B2 (en)2015-08-06
SG193578A1 (en)2013-10-30
IL228555A0 (en)2013-12-31
CO6801756A2 (en)2013-11-29
AR088735A1 (en)2014-07-02
EP2694518B1 (en)2015-10-07
EA201301111A1 (en)2014-02-28
ZA201307085B (en)2015-04-29
JP2014509637A (en)2014-04-21
AP2013007198A0 (en)2013-10-31
RS54458B1 (en)2016-06-30
PT2694518E (en)2016-02-05
WO2012131379A1 (en)2012-10-04
SMT201500322B (en)2016-02-25
HK1193096A1 (en)2014-09-12
CY1117025T1 (en)2017-04-05
ME02314B (en)2016-06-20
GB201105659D0 (en)2011-05-18
TWI516265B (en)2016-01-11
DK2694518T3 (en)2015-11-09
TW201244720A (en)2012-11-16
HUE028438T2 (en)2017-02-28
CN103492392B (en)2015-11-25
MA35064B1 (en)2014-04-03
HRP20151340T1 (en)2016-02-26
JP5826374B2 (en)2015-12-02
CA2831493A1 (en)2012-10-04
BR112013025236A2 (en)2019-09-24
NZ615621A (en)2015-01-30
EP2694518A1 (en)2014-02-12
CN103492392A (en)2014-01-01
US20140206703A1 (en)2014-07-24
CU24173B1 (en)2016-04-25
MX2013011301A (en)2014-04-16
CU20130124A7 (en)2014-01-29
ECSP13012988A (en)2013-12-31
AU2012235882A1 (en)2013-05-02
HK1193806A1 (en)2014-10-03
KR20140023332A (en)2014-02-26
ES2558563T3 (en)2016-02-05
SI2694518T1 (en)2016-02-29
PE20141021A1 (en)2014-08-30
NI201300100A (en)2014-01-07
PH12013501952A1 (en)2018-04-11
GT201300225A (en)2014-12-30
MX335937B (en)2016-01-04
CL2013002789A1 (en)2014-07-18
RU2013148627A (en)2015-05-10
TN2013000377A1 (en)2015-01-20

Similar Documents

PublicationPublication DateTitle
GT201200321A (en) DERIVATIVES OF HETEROARIL IMIDAZOLONA AS JAK INHIBITORS
CL2016001604A1 (en) "Compounds derived from pyrazolo [1,5-a] pyridine, axl and c-met kinase inhibitors; pharmaceutical composition comprising them; and its use in cancer treatment. ” pct
MX2021000007A (en) ENZALUTAMIDE FORMULATIONS.
PH12016500024A1 (en)Bromodomain inhibitor
UY34220A (en) INDAZOLS, PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME
ECSP14017269A (en) COMPOUNDS TO TREAT SPINAL MUSCULAR ATROPHY
CL2016001231A1 (en) Autotaxin Inhibitor Compounds
PE20151778A1 (en) COMBINED FORMULATION OF TWO ANTIVIRAL COMPOUNDS
NI201300041A (en) SPIRO-OXINDOL MDM2 ANTAGONISTS
CL2013002517A1 (en) Compounds derived from 5-fluoro-2'-deoxyuridine phosphoramidate; preparation procedure; pharmaceutical composition that includes them; its use in the treatment or prophylaxis of cancer.
CL2015003801A1 (en) Antibody formulations and methods
AR089993A1 (en) PEPTIDOMIMETIC MACROCICLES
GT201400147A (en) PYRIMIDINES AND FUSIONATED TRIAZINS REPLACED AND ITS USE
MX376329B (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTIC ACTIVE COMPOUNDS AND THEIR METHODS OF USE.
CL2012002189A1 (en) Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors.
MX349796B (en) PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT OF ONCOLOGICAL DISORDERS THROUGH THE USE OF COENZYME Q10.
MX362215B (en)2-aminopyrido[4,3-d]pyrimidin-5-one derivatives and their use as wee-1 inhibitors.
GT201400111A (en) SUBSTITUTED TRIAZOLOPIRIDINS
UY34278A (en) NEW NOXEDINE DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF DISEASES
GT201400017A (en) DERIVATIVES OF PIRIDIN-2 (1H) -ONA AS JAK INHIBITORS
DOP2014000036A (en) PIRIDAZINONE COMPOUNDS AND ITS USE AS DAAO INHIBITORS
EA201691032A1 (en) IZHOCHROMEN DERIVATIVES AS PHOSFOINOSYTID-3-KINAZ INHIBITORS
MX2016016583A (en) INDOLIZINE DERIVATIVES AS INHIBITORS OF PHOSFOINOSITIDO-3 KINASES.
UY34018A (en) GLUCOSIDE DERIVATIVES AND USES OF THE SAME
UA115357C2 (en)Pyridin-4-yl derivatives

Legal Events

DateCodeTitleDescription
FAAbandonment or withdrawal (granting procedure)
[8]ページ先頭
©2009-2025 Movatter.jp